Drug intelligence / Profile preview

Patacure-KT

Development stage
Unknown
Lead developer
Martia Laboratories
Modality
Small Molecules
Administration
Ophthalmic
01

Overview

Patacure-KT is a fixed-dose combination ophthalmic solution marketed by Martia Laboratories for the treatment of allergic conjunctivitis. It contains two active pharmaceutical ingredients: olopatadine hydrochloride and ketorolac tromethamine. Olopatadine is a dual-action agent that functions as a selective histamine H1 receptor antagonist and a mast cell stabilizer, providing rapid relief from ocular itching and preventing the release of inflammatory mediators. Ketorolac tromethamine is a non-steroidal anti-inflammatory drug (NSAID) that inhibits the cyclooxygenase (COX-1 and COX-2) enzymes, thereby reducing prostaglandin synthesis and alleviating ocular pain and inflammation. This combination is specifically formulated for topical ophthalmic use to manage both the allergic and inflammatory components of seasonal or perennial allergic conjunctivitis.

Brand names
Patacure-KT
Other names
Patacure-KT Eye Dropsolopatadine + ketorolac eye drops
02

Targets

PTGS2 (Prostaglandin-Endoperoxide Synthase 2)PGHS-1 (Prostaglandin G/H Synthase 1)HRH1 (Histamine H1 Receptor)

Beyond the preview

Go deeper on Patacure-KT.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Patacure-KT.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call